Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
BIOMES logo — Health prevention based on genomics: because well-being is e...

BIOMES

Health prevention based on genomics: because well-being is encoded in our DNA.

Founded 2017 Germany Wildau, Germany 37 employees Total: $4.00M

General Information

Company Name BIOMES
Founded Year 2017
Location Germany Wildau, Germany
Founders / Decision Makers
Team member
Employees 37
Social

BounceWatch is an independent company data service, not affiliated with BIOMES. To contact BIOMES, visit biomes.world.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BIOMES compare?

A PDF of BIOMES and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BIOMES soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BIOMES

BIOMES is a biotech startup focusing on health prevention through genomic analysis. Founded in 2017 and headquartered in Germany, the company offers scientific self-testing kits to understand the human microbiome. BIOMES uses high-throughput DNA sequencing, machine learning, and community engagement to analyze the microbiome and provide evidence-based recommendations for individuals to restore their gut balance naturally. The company's flagship product, INTEST.pro, is a DNA-based gut microbiome analysis that offers personalized health insights and actionable recommendations. Through a process that involves sending a stool sample to their lab in Wildau, Germany, BIOMES extracts and analyzes the DNA to empower users to make informed decisions about their well-being. With a focus on Big Data, Biotechnology, Health Care, Health and Wellness, Life Sciences, Nutrition, Clean Energy, and Lifestyle, BIOMES has garnered the attention of investors. In its Corporate Round investment at 20 November 2024, the company secured funding from Keiyo Gas, showcasing the investor interest in the promising capabilities of BIOMES in the genomics and health sector.

Business keywords: Genomics, Microbiome Analysis, Health Tech, DNA Sequencing, Personalized Medicine, Scientific Research, Health Prevention, Wellness, Gut Health, Biotech Startups, Digital Healthcare, Community Health

Services & Products

Microbiome analysis and personalized nutrition recommendations

Target Customers

Individuals seeking personalized health insights and nutritional guidance

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC Undisclosed 1
Keiyo Gas Energy Solution
01 Nov 2024
Seed €2.00M -
01 Dec 2020
Early VC €2.00M 1
Yabeo
Yabeo
01 Feb 2020
Spinout Undisclosed 1
Technical College Wildau
01 Nov 2017

BIOMES Alternatives & Competitors

View All Alternatives
BIOMES vs
Genoplan
Genoplan Korea South

유전자 정보의 대중화를 선도하는 글로벌 생명공학 기업 제노플랜코리아 입니다.

Series C
16 employees
AI, Analytics
Compare BIOMES vs Genoplan
BIOMES vs
Comite Center for Precision Medicine & Healthy Longevity
Comite Center for Precision Medicine & Healthy Longevity United States

Comite Center for Precision Medicine & Health is a one-of-a-kind personalized practice in New York,...

29 employees
Health Care
Compare BIOMES vs Comite Center for Precision Medicine & Healthy Longevity
BIOMES vs
HiDNA
HiDNA Turkey

DNA Based Future!

5 employees
Biotechnology, Deep Tech
View all alternatives

FAQ About BIOMES

Health prevention based on genomics: because well-being is encoded in our DNA.
BIOMES was founded in 2017.
BIOMES is headquartered in Wildau, Germany.
BIOMES has approximately 37 employees.
BIOMES has completed 4 funding rounds, raising a total of $4.00M.
BIOMES offers: Microbiome analysis and personalized nutrition recommendations.
Top alternatives and competitors to BIOMES include Genoplan , Comite Center for Precision Medicine & Healthy Longevity, HiDNA, Kean Health, Phase Genomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BIOMES and Genoplan are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BIOMES, https://bouncewatch.com/company/biomes, updated 6 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout